Phage Display Identification of CD100 in Human Atherosclerotic Plaque Macrophages and Foam Cells

Show simple item record

dc.contributor Sistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP
dc.contributor.author LUQUE, Maria Carolina Aquino
GUTIERREZ, Paulo Sampaio FMUSP-HC
DEBBAS, Victor FMUSP-HC
MARTINS, Waleska Kerllen
PUECH-LEAO, Pedro FMUSP-HC
PORTO, Georgia
COELHO, Veronica FMUSP-HC
BOUMSELL, Laurence
KALIL, Jorge FMUSP-HC
STOLF, Beatriz
dc.date.issued 2013
dc.identifier.citation PLOS ONE, v.8, n.9, article ID e75772, 9p, 2013
dc.identifier.issn 1932-6203
dc.identifier.uri http://observatorio.fm.usp.br/handle/OPI/3852
dc.description.abstract Atherosclerosis is a complex disease in which vessels develop plaques comprising dysfunctional endothelium, monocyte derived lipid laden foam cells and activated lymphocytes. Considering that humans and animal models of the disease develop quite distinct plaques, we used human plaques to search for proteins that could be used as markers of human atheromas. Phage display peptide libraries were probed to fresh human carotid plaques, and a bound phage homologous to plexin B1, a high affinity receptor for CD100, was identified. CD100 is a member of the semaphorin family expressed by most hematopoietic cells and particularly by activated T cells. CD100 expression was analyzed in human plaques and normal samples. CD100 mRNA and protein were analyzed in cultured monocytes, macrophages and foam cells. The effects of CD100 in oxLDL-induced foam cell formation and in CD36 mRNA abundance were evaluated. Human atherosclerotic plaques showed strong labeling of CD100/SEMA4D. CD100 expression was further demonstrated in peripheral blood monocytes and in in vitro differentiated macrophages and foam cells, with diminished CD100 transcript along the differentiation of these cells. Incubation of macrophages with CD100 led to a reduction in oxLDL-induced foam cell formation probably through a decrease of CD36 expression, suggesting for the first time an atheroprotective role for CD100 in the human disease. Given its differential expression in the numerous foam cells and macrophages of the plaques and its capacity to decrease oxLDL engulfment by macrophages we propose that CD100 may have a role in atherosclerotic plaque development, and may possibly be employed in targeted treatments of these atheromas.
dc.description.sponsorship · FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo)
dc.language.iso eng
dc.publisher PUBLIC LIBRARY SCIENCE
dc.relation.ispartof Plos One
dc.rights openAccess
dc.subject.other surface expression; scavenger receptors; soluble cd100; activation; lesions; growth; gamma
dc.title Phage Display Identification of CD100 in Human Atherosclerotic Plaque Macrophages and Foam Cells
dc.type article
dc.rights.holder Copyright PUBLIC LIBRARY SCIENCE
dc.description.group LIM/19
dc.description.group LIM/28
dc.description.group LIM/02
dc.identifier.doi 10.1371/journal.pone.0075772
dc.identifier.pmid 24098722
dc.type.category original article
dc.type.version publishedVersion
hcfmusp.author GUTIERREZ, Paulo Sampaio:HC:INCOR
hcfmusp.author DEBBAS, Victor:FM:MCP
hcfmusp.author PUECH-LEAO, Pedro:FM:MCG
hcfmusp.author COELHO, Veronica:HC:INCOR
hcfmusp.author KALIL, Jorge:FM:MCM
hcfmusp.author.external · LUQUE, Maria Carolina Aquino:HC FMUSP, Heart Inst Sao Paulo InCor, Sao Paulo, Brazil; Univ Sao Paulo, Sch Med, Dept Clin Med, HC FMUSP, Sao Paulo, Brazil
· MARTINS, Waleska Kerllen:Univ Sao Paulo, Inst Chem, Dept Biochem, Sao Paulo, Brazil
· PORTO, Georgia:HC FMUSP, Heart Inst Sao Paulo InCor, Sao Paulo, Brazil
· BOUMSELL, Laurence:Univ Paris 05, Inst Cochin, INSERM, U567, Paris, France
· STOLF, Beatriz:HC FMUSP, Heart Inst Sao Paulo InCor, Sao Paulo, Brazil; Univ Sao Paulo, Sch Med, Dept Clin Med, HC FMUSP, Sao Paulo, Brazil; Univ Sao Paulo, Dept Parasitol, Inst Biomed Sci, Sao Paulo, Brazil
hcfmusp.origem.id 2-s2.0-84884738667
hcfmusp.origem.id WOS:000325423500093
hcfmusp.publisher.city SAN FRANCISCO
hcfmusp.publisher.country USA
hcfmusp.relation.reference · Arap MA, 2004, CANCER CELL, V6, P275, DOI 10.1016/j.ccr.2004.08.018
· BANKA CL, 1991, J LIPID RES, V32, P35
· BOUGERET C, 1992, J IMMUNOL, V148, P318
· Bover LC, 2007, J IMMUNOL, V178, P8183
· Chabbert-de Ponnat I, 2005, INT IMMUNOL, V17, P439, DOI 10.1093/intimm/dxh224
· Cominacini L, 2000, J BIOL CHEM, V275, P12633, DOI 10.1074/jbc.275.17.12633
· Elhabazi A, 2001, J IMMUNOL, V166, P4341
· Elhabazi A, 2003, CRIT REV IMMUNOL, V23, P65, DOI 10.1615/CritRevImmunol.v23.i12.40
· Greaves DR, 2005, J LIPID RES, V46, P11, DOI 10.1194/jlr.R400011-JLR200
· Hansson GK, 2006, NAT REV IMMUNOL, V6, P508, DOI 10.1038/nri1882
· Hansson GK, 2011, NAT IMMUNOL, V12, P204, DOI 10.1038/ni.2001
· Hong HY, 2008, J CELL MOL MED, V12, P2003, DOI [10.1111/j.1582-4934.2008.00189.x, 10.1111/j.1582-4934.2007.00189.x]
· Houston P, 2001, FEBS LETT, V492, P73, DOI 10.1016/S0014-5793(01)02191-3
· Hu Y, 2008, J IMMUNOL, V180, P8057
· Ji JD, 2009, HUM IMMUNOL, V70, P211, DOI 10.1016/j.humimm.2009.01.026
· Kamperidis P, 2011, ARTHRITIS RHEUM-US, V63, P3758, DOI 10.1002/art.30650
· Karjalainen K, 2011, BLOOD, V117, P920, DOI 10.1182/blood-2010-05-282921
· Kikutani H, 2007, ADV IMMUNOL, V93, P121, DOI 10.1016/S0065-2776(06)93003-X
· KOLODKIN AL, 1993, CELL, V75, P1389, DOI 10.1016/0092-8674(93)90625-Z
· Krieger M, 1997, CURR OPIN LIPIDOL, V8, P275, DOI 10.1097/00041433-199710000-00006
· Pasqualini R, 1996, NATURE, V380, P364, DOI 10.1038/380364a0
· Porto G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021702
· Rajotte D, 1998, J CLIN INVEST, V102, P430, DOI 10.1172/JCI3008
· Rekhter MD, 2001, CELL BIOCHEM BIOPHYS, V35, P103, DOI 10.1385/CBB:35:1:103
· Robert R, 2006, J BIOL CHEM, V281, P40135, DOI 10.1074/jbc.M609344200
· Schroder K, 2004, J LEUKOCYTE BIOL, V75, P163, DOI 10.1189/jlb.0603252
· Sierra JR, 2008, J EXP MED, V205, P1673, DOI 10.1084/jem.20072602
· Stary HC, 1995, AM HEART ASS, V92, P1355
· STARY HC, 1994, CIRCULATION, V89, P2462
· Steinberg D, 1997, J BIOL CHEM, V272, P20963, DOI 10.1074/jbc.272.34.20963
· Yacoby I, 2008, EXPERT OPIN DRUG DEL, V5, P321, DOI 10.1517/17425247.5.3.321
· Yukawa K, 2010, INT J MOL MED, V26, P39, DOI 10.3892/ijmm_00000432
· Zhu L, 2007, P NATL ACAD SCI USA, V104, P1621, DOI 10.1073/pnas.0606344104
· Zhu L, 2009, ARTERIOSCL THROM VAS, V29, P1039, DOI 10.1161/ATVBAHA.109.185405
dc.description.index MEDLINE
hcfmusp.citation.scopus 10
hcfmusp.citation.wos 10
hcfmusp.affiliation.country Brasil
hcfmusp.affiliation.country França


Files in this item

This item appears in the following Collection(s)

Show simple item record

Search DSpace



Browse

My Account

Statistics